Technology Select Sector

S&P 500

The Balanced Allocator

Comparable Companies - ARM

No open-market insider purchases or sales in the last 12 months. Top institutional holders are Goldman Sachs Group Inc (0.4%), Morgan Stanley (0.4%), Sustainable Growth Advisers, LP (0.3%). Latest short interest as of 2026-03-13 is 14,711,957 shares or 1.4% of float.

Continues to lead the company following the 2023 IPO and through the 2025 fiscal year expansion into AI-centric compute platforms.

Chief Executive Officer and Director

Remains in role; oversaw the financial transition from a private SoftBank subsidiary to a high-performing public entity.

Executive Vice President and Chief Financial Officer

Maintains chairmanship representing SoftBank Group Corp.'s majority ownership stake.

Chairman of the Board

Continues service on the board; historically a key advisor to Masayoshi Son at SoftBank.

Director

Remains on the board; brings extensive semiconductor experience from Samsung and Intel.

Verified as a current independent director with significant Intel executive history.

Continues as a director; currently serves as CEO of GlobalFoundries while maintaining his seat at Arm.

Remains an independent director and Audit Committee member.

Continues service; Co-Founder of The Raine Group.

Verified in current role overseeing legal and M&A strategy.

Executive Vice President, Chief Legal Officer & Head of Corporate Development

Remains the technical lead for Arm's architecture development.

Executive Vice President, Chief Architect and Fellow

Rene Haas

Jason Child

Masayoshi Son

Paul Jacobs

Young Sohn

Rene Haas represents a rare combination of technical depth and capital markets execution. His provenance is rooted in the high-growth era of NVIDIA, which he successfully translated into a strategic overhaul of Arm's licensing model. By shifting Arm's focus from mobile-centricity to high-performance computing and AI, Haas has decoupled the company's valuation from the smartphone cycle. His successful navigation of the 2023 IPO under intense market scrutiny demonstrates a high level of institutional credibility and operational discipline.

Initial Public Offering (IPO) of Arm Holdings plc

Jason Child is a 'scale specialist' CFO with a track record of navigating complex business model transformations at Amazon and Splunk. His appointment at Arm was a clear signal of the company's intent to professionalize its financial reporting and investor relations ahead of its IPO. Child's history of managing high-growth, high-margin tech businesses provides Arm with the necessary fiscal rigor to maintain its premium valuation in the public markets. His experience with cloud-native economics is particularly relevant as Arm expands its footprint in the hyperscale data center market.

Ronald D. Fisher

Rosemary Schooler

Jeffrey Sine

Karen Dykstra

Qualcomm operates a dual business model of semiconductor chip sales (QCT) and intellectual property licensing (QTL).

Development and supplier of integrated circuit products and system software for mobile, automotive, and IoT.

Licensing of intellectual property portfolio including standard-essential patents for wireless technologies.

Strategic investments through Qualcomm Ventures.

Texas Instruments is a leading manufacturer of analog and embedded processing semiconductors with a focus on industrial and automotive markets.

Semiconductors that condition, amplify, and convert real-world signals.

Microcontrollers and processors for embedded applications.

Marvell is a fabless semiconductor company focusing on data center, networking, and storage solutions.

Design and sale of integrated circuits for data center, networking, and storage.

NXP Semiconductors is a leading supplier of automotive and industrial semiconductors with a broad portfolio of microcontrollers, processors, and analog products.

Arm's global headquarters are located in Cambridge, UK (approximately 418,793 square feet of leased office space), with additional leased facilities in Europe, North America, Asia-Pacific and other regions; leasehold improvements were $167 million and equipment $603 million as of March 31, 2025, all recorded as net property and equipment of $394 million

Arm's financial story reflects explosive 23.9% FY2025 revenue growth to $4,007M from AI licensing and royalties, 20.7% operating margins, and net-cash position funding 51.7% R&D reinvestment, but with $984M SBC diluting per-share value. This hypergrowth team shines in disciplined capital deployment to internal scaling, CEO's proven IPO execution, and expert board oversight, yet falters on minimal executive skin-in-the-game, rendering them well-suited for AI TAM capture but requiring alignment fixes for sustained public-market trust.

The company is subject to environmental, health and safety regulations in various jurisdictions including the U.K., European Union, U.S., and PRC. They monitor changes and believe they are in material compliance with applicable laws, but non-compliance could result in investigations, sanctions, and adverse effects on business.

As of March 31, 2025, the company had 8,330 global employees across 19 countries, with 83% engaged in engineering. Average temporary employees for fiscal year 2025 was 2,054. Employees in France and Hungary are represented by works councils with productive relationships. No work stoppages reported.

The company addresses product security, data privacy, and compliance with regulations such as GDPR, U.K. GDPR, and CCPA. They have cybersecurity policies and practices, but face risks from security vulnerabilities and non-compliance with data protection laws, which could lead to penalties and reputational damage.

The company faces supply chain risks due to geopolitical tensions, trade regulations, and reliance on customers and partners. They monitor compliance with laws but do not disclose specific responsible sourcing or community initiatives.

Revenue grew 26% YoY to $4.67 B TTM, operating margin surged to 20.7% in FY2025, but R&D consumes >50% of revenue and share‑based compensation equals $984 M TTM, creating a cash‑conversion dip to 0.5× in FY2025.

The Innovation Dossier describes CapEx as primarily lease‑hold improvements and equipment to support licensing operations, while transcript commentary repeatedly highlights accelerated R&D to deliver next‑gen compute subsystems, chiplets and AI accelerators, with no mention of dividend or buyback programs.

No material impairments were disclosed in the 20‑F or Material Events, and the auditor did not flag any impairment as a Critical Audit Matter, indicating that the tangible book is reliable; however, intangibles (IP portfolio) dominate the balance sheet and are subject to valuation uncertainty.

The Innovation Dossier and transcript highlight heavy R&D into CSS, chiplets and AI accelerators, yet the negative incremental ROIC suggests that the latest R&D spend has not yet generated returns above the 15% discount rate, implying potential value destruction in the short term.

EV/Sales

P/Tangible Book

EV/EBITDA

Charlotte Eaton

Jeffrey A. Sine

Karen E. Dykstra

Mr. Fisher

Mr. Sohn

Mr. Son

SoftBank Group Corp.

Paul E. Jacobs, PhD

Spencer Collins

Richard Grisenthwaite

Will Abbey

All Senior Management and Directors as a group (13 individuals)

Chair of the Board

Ms. Schooler

Dr. Jacobs

Rene Anthony Andrada Haas

Chief Executive Officer & Director

Laura Bartels

Chief Accounting Officer

Eric Hayes

Executive Vice President of Operations

Ian Thornton

Head of Investor Relations

Jason E. Child

Executive VP & CFO

Jeffrey Thomas Kvaal

Vice President & Head of Investor Relations

Executive VP & Chief Architect

William Abbey

Executive VP & Chief Commercial Officer

Ami Badani

Chief Marketing Officer

Chief People Officer

Arm designs and licenses semiconductor processor architectures, CPU designs, accelerator IP, and related software ecosystems. It generates revenue primarily through licensing agreements and royalties from customers that integrate Arm IP into chips for smartphones, consumer electronics, data centers, automotive, IoT and other markets. The company operates globally with a network of partners and a long-standing presence in mobile applications processors where it holds >99% market share.

The company operates as a single reporting segment that encompasses all licensing, royalty and other revenue activities worldwide.

Held base margins, 20x terminal EV/EBITDA, and 15% WACC constant; solved for revenue CAGR equating DCF to current EV of 140960.0.

Balance Sheet - Supplemental

Balance Sheet

Cash Flow Statement - Supplemental

Cash Flow Statement

Income Statement - Supplemental

Income Statement

Ratios

Valuation

Historical Ratios & Multiples - ARM

The semiconductor industry is in a 'Golden Age' where revenue growth is outpacing capital expenditures. However, Arm is uniquely exposed to geopolitical risks in China (21-25% of revenue) and the Taiwan Strait, which serves as a single point of failure for its manufacturing partners like TSMC.

Arm is at a critical juncture as the initial AI IPO hype meets the reality of decelerating royalty guidance and a major legal trial in March 2026.

Qualcomm Litigation Trial (March 2026). A verdict or settlement will resolve the uncertainty surrounding Arm's licensing terms with one of its largest customers.

Q4 FY2026 Revenue Guidance. Management guided to $1.47B, representing 18% YoY growth. A miss here would signal the start of the feared royalty deceleration.

Valuation Compression. The stock trades at 169x forward P/E, a level that leaves no room for error. Any deceleration in growth will lead to a violent re-rating.

Geopolitical and China Exposure. 21-25% of revenue is derived from China, which is subject to evolving US export controls.

The stewardship verdict is 'Adequate but Conflicted.' The Governance Outcome Tree suggests three paths: 1. Status Quo: SoftBank maintains its 87% stake, keeping the float thin and multiples high. 2. Strategic Exit: SoftBank sells a significant block, causing a massive supply overhang and price compression. 3. Diversification: SoftBank slowly trims, leading to a multi-year valuation grind as the 'scarcity premium'...

Liquidation value analysis is not relevant for the company's archetype ('Early-Stage_Hypergrowth') and was not performed.

Arm Holdings plc reported Q3 FY2026 results on February 4, 2026

Arm upgraded to Positive from Neutral at Susquehanna

Arm Holdings plc held 2025 Annual General Meeting on September 9, 2025

Arm Holdings plc reported Q1 FY2026 results on July 30, 2025

Arm Holdings plc reported Q4 FY2025 and full-year results on May 7, 2025

U. S. Investors Get Currency-Hedged Solutions To Leading International Semiconductor Names, Toyota Motors With New Adrhedged™ Etfs From Precidian Investments

Arm Holdings plc reported Q3 FY2025 results on February 5, 2025

Citi Reiterates Buy Rating on Arm Holdings (ARM)

Arm Holdings plc held 2024 Annual General Meeting on September 11, 2024

Arm Holdings plc announced 2024 Annual General Meeting on September 11, 2024

Daiwa Securities Upgrades Arm Holdings (ARM) to Outperform (2)

Bernstein SocGen Group Upgrades Arm Holdings (ARM) to Market Perform

Arm Holdings plc reported Q1 FY2025 results on July 31, 2024

Arm downgraded to Neutral from Outperform at Exane BNP Paribas

SoftBank Group Corp. filed Schedule 13G showing 89.8% ownership of Arm Holdings plc

What's Going On With British Chipmaker Arm Stock Monday?

Arm Holdings plc reported Q3 FY2024 results on February 7, 2024

Why Is Semiconductor Company Arm Holdings Stock Trading Higher Monday?

Arm Holdings plc reported Q2 FY2024 results on November 8, 2023

Arm price target lowered to $170 from $205 at Jefferies

Arm initiated with an Outperform at RBC Capital

ODDO BHF Upgrades Arm Holdings (ARM) to Outperform

Arm downgraded to Sell from Neutral at Goldman Sachs

Situation: Current price is $134.96 versus fair value $56.69 (-58.0% expected return), and valuation confidence is partial. Debate: Bull case depends on Qualcomm Litigation Trial (March 2026). Bear case centers on Valuation Compression. Conclusion: Recommendation is Sell with no position, pending a materially better risk/reward setup.

Executive Summary

The primary value driver is a necessary mean reversion as the market reconciles Arm's elite 97.5% gross margins with its decelerating royalty growth, which management guided to the low-teens. This correction will likely be triggered by a combination of revenue growth normalization and the March 2026 trial regarding the Qualcomm licensing dispute. Downside protection is limited to the company's $2.8B cash fortress, which provides a floor far below current trading levels.<ul><li>Driver: Valuation Mean Reversion</li><li>Catalyst: Deceleration in Royalty Growth and Legal Setbacks</li><li>Protection: Net Cash Position of $2.8B</li></ul>Our variant perception is that the market is excessively discounting the stock's valuation risks due to AI euphoria, failing to recognize that the underlying unit economics, while strong, are being offset by massive R&D reinvestment consuming 56% of TTM revenue. Furthermore, the market underestimates the threat of RISC-V commoditization and the impact of the Qualcomm litigation, which could impair a key customer relationship and royalty stream.This is a valuation-driven exit recommendation on a high-growth technology leader where the bet is that the current 'Blue Sky' scenario is fully priced in, leaving no margin of safety for execution failure or competitive displacement.

Core Investment Rationale

Arm operates a high-margin intellectual property (IP) licensing and royalty model. The company architects central processing units (CPUs) and related technologies that power 99% of the world's premium smartphones. Revenue is bifurcated into Licensing (upfront fees for access to IP) and Royalties (per-unit fees on shipped chips). Strategy has recently shifted toward Compute Subsystems (CSS), which are pre-integrated, higher-margin configurations designed to capture a larger share of the AI data center and automotive markets. TTM revenue stands at $4.67B, representing 26.4% year-over-year growth.The core of Arm's moat is the Armv9 architecture and the Neoverse platform, which are increasingly adopted by hyperscalers like AWS (Graviton) and Google (Axion). The company's intangible asset base is massive, with 8,150 issued patents as of March 2025. These assets create significant switching costs; customers who integrate Arm IP face months of redesign and re-qualification if they attempt to switch architectures, effectively locking them into the Arm ecosystem.Arm operates in an oligopolistic IP landscape alongside Synopsys and Cadence Design Systems. While Arm dominates mobile, it faces intense competition in the data center and IoT markets from the open-source RISC-V architecture and legacy x86 providers. Despite this, Arm maintains a superior gross margin of 97.5%, which is 16.8 percentage points above the peer median of 80.8%, confirming its dominant pricing power in its core segments.Following its 2023 IPO, which raised $4.87B, Arm has transitioned from a private SoftBank subsidiary to a high-growth public entity. The current situation is defined by a massive pivot toward AI-centric compute platforms under CEO Rene Haas. However, the defining context for investors is the 87% majority stake held by SoftBank Group Corp. This concentration limits board independence and creates a structural float constraint. Furthermore, the company is currently embroiled in a high-stakes legal battle with Qualcomm, with a trial scheduled for March 2026 that could redefine licensing terms for one of its largest customers.

Business & Situation

<ul><li>Bull Case: Arm captures 50% of the hyperscaler CPU market by 2030, driving a 76% CAGR in data center royalty revenue. The transition to Armv9 and CSS continues to expand royalty rates, offsetting any volume stagnation in smartphones.</li><li>Bear Case: Valuation at 169x forward P/E is unsustainable as royalty growth decelerates to low-teens. RISC-V gains significant traction in data centers, commoditizing the architecture and eroding Arm's pricing power.</li></ul>The consensus view is that Arm is the 'indispensable' architecture for the AI era, justified by its 99% mobile share and rapid adoption by cloud giants. This narrative has driven the stock to a $141B Enterprise Value, treating it as a pure-play AI infrastructure winner with unlimited margin expansion potential. Our analysis suggests this narrative ignores the reality of R&D intensity. Arm's R&D spend consumes 51.7% of revenue, and while operating margins have rebounded to 20.7%, they remain well below the 30-40% levels seen in mature software-style IP businesses.The semiconductor industry is in a 'Golden Age' where revenue growth is outpacing capital expenditures. However, Arm is uniquely exposed to geopolitical risks in China (21-25% of revenue) and the Taiwan Strait, which serves as a single point of failure for its manufacturing partners like TSMC.Our differentiated view is that the market is fixated on current revenue beats while underestimating the long-term impact of SoftBank's 87% ownership and the potential for a 'valuation air pocket' if SoftBank begins to trim its stake. Furthermore, the Qualcomm litigation is not merely a legal nuisance but a structural threat to the licensing model. If Qualcomm succeeds in its countersuit for improper interference, it could trigger a re-pricing of Arm's entire royalty structure across the mobile ecosystem.While Arm is an exceptional business with a widening moat in CSS, the current price requires a level of perfection in execution and market share capture that is historically rare. At $134.96, the risk-reward is heavily skewed to the downside.Our analytical edge is a focus on underlying unit economics and the reconciliation of the 'Rule of 40' metrics, which indicate that Arm's current valuation implies a growth-and-margin profile that exceeds even the most optimistic hyperscale precedents.

Core Thesis

CEO Rene Haas is a high-quality leader with deep technical roots, having previously managed NVIDIA's dominant GPU business. He successfully navigated the 2023 IPO and the pivot to AI. However, his alignment with minority shareholders is weak, as he holds only 351,433 shares (less than 0.1% of the company).Management has shown exceptional discipline in reinvestment, channeling 35.8% of operating cash flow into R&D and CapEx. However, there have been zero share repurchases or dividends, and the company recently issued $35M in stock, resulting in modest dilution despite a $2.8B cash balance.Management's communication is generally candid, though they have been criticized for withholding full-year guidance during periods of tariff uncertainty, which tested their credibility with the sell-side.<ul><li>Board Independence: 60% (3 of 5 directors)</li><li>Chairman/CEO Roles: Separate (Masayoshi Son is Chairman; Rene Haas is CEO)</li><li>Chairman Tenure: Since 2023 (Post-IPO)</li><li>Insider Ownership: 87% (SoftBank Group Corp.)</li><li>Shareholder Rights: Controlled Company; Plurality Voting</li></ul>The stewardship verdict is 'Adequate but Conflicted.' The Governance Outcome Tree suggests three paths: 1. Status Quo: SoftBank maintains its 87% stake, keeping the float thin and multiples high. 2. Strategic Exit: SoftBank sells a significant block, causing a massive supply overhang and price compression. 3. Diversification: SoftBank slowly trims, leading to a multi-year valuation grind as the 'scarcity premium' evaporates. In all scenarios, minority shareholders are secondary to SoftBank's capital needs.

Leadership & Governance

The valuation floor is set at $27.41, representing the Bear Case DCF Value. This serves as the ultimate backstop in a 'broken growth' scenario where RISC-V competition accelerates and China revenue is impaired.Base Case ($41.67): Assumes 22% revenue CAGR and operating margins reaching 32% by Year 5 as R&D intensity fades. This reflects balanced execution of the CSS strategy.Bull Case ($54.82): Assumes rapid CSS adoption with a 50% royalty mix and 50% data center share, with revenue growth 8 percentage points above the base case.Bear Case ($27.41): Assumes RISC-V commoditization and China export controls displace share, with royalty growth decelerating to 15% in Year 1 and margins eroding to 19%.

Valuation Context

<ul><li>Qualcomm Litigation Trial (March 2026). A verdict or settlement will resolve the uncertainty surrounding Arm's licensing terms with one of its largest customers.</li><li>Q4 FY2026 Revenue Guidance. Management guided to $1.47B, representing 18% YoY growth. A miss here would signal the start of the feared royalty deceleration.</li><li>Arm is at a critical juncture as the initial AI IPO hype meets the reality of decelerating royalty guidance and a major legal trial in March 2026.</li></ul>Arm is at a critical juncture as the initial AI IPO hype meets the reality of decelerating royalty guidance and a major legal trial in March 2026.

Catalyst Path & Context

<ul><li>Valuation Compression. The stock trades at 169x forward P/E, a level that leaves no room for error. Any deceleration in growth will lead to a violent re-rating. Current EV/Sales of 30.2x is significantly above the peer median of 12.5x.</li><li>Geopolitical and China Exposure. 21-25% of revenue is derived from China, which is subject to evolving US export controls. Ongoing lawsuits in China initiated by the former CEO of Arm China challenge corporate governance.</li><li>The stewardship verdict is 'Adequate but Conflicted.' The Governance Outcome Tree suggests three paths: 1. Status Quo: SoftBank maintains its 87% stake, keeping the float thin and multiples high. 2. Strategic Exit: SoftBank sells a significant block, causing a massive supply overhang and price compression. 3. Diversification: SoftBank slowly trims, leading to a multi-year valuation grind as the 'scarcity premium'... Risk monitor: Current price $134.96 vs fair value $56.69, expected return -58.0%.</li></ul>

Primary Risks

<ul><li>Entry Target: No new entries: recommendation is Sell.</li><li>Stop Loss: No stop-loss needed because recommendation is Sell (no position).</li><li>Position Size: Position size is None under current recommendation and risk constraints.</li><li>Time Horizon: N/A for a Sell recommendation.</li></ul><ul><li>Court filings indicate a trial for Qualcomm's countersuit for improper interference is scheduled for March 2026.</li><li>Management's commentary in the February 2026 earnings call set the midpoint at $1.47B.</li><li>Current EV/Sales of 30.2x is significantly above the peer median of 12.5x.</li></ul>Unexplained revenue deceleration. If revenue growth falls below 20% without a corresponding 500bp improvement in operating margin, the hypergrowth thesis is dead. Also require valuation reliability to improve before re-entering.

Actionable Parameters & Monitoring

ARM appears overvalued (fair value $56.69 vs current $134.96, expected return -58.0%). Recommendation: Sell; do not allocate until valuation and risk profile reset.

Final Conclusion

Driver

Deceleration in Royalty Growth and Legal Setbacks

Catalyst

Protection

Arm captures 50% of the hyperscaler CPU market by 2030, driving a 76% CAGR in data center royalty revenue. The transition to Armv9 and CSS continues to expand royalty rates, offsetting any volume stagnation in smartphones.

Bull Case

Valuation at 169x forward P/E is unsustainable as royalty growth decelerates to low-teens. RISC-V gains significant traction in data centers, commoditizing the architecture and eroding Arm's pricing power.

Bear Case

Situation: Current price is $134.96 versus fair value $56.69 (-58.0% expected return), and valuation confidence is partial. Debate: Bull case depends on Qualcomm Litigation Trial (March 2026). Bear case centers on Valuation Compression. Conclusion: Recommendation is Sell with no position, pending a materially better risk/reward setup.

The strategic narrative evolved from a broad focus on AI-driven v9 adoption across all segments to a concentrated emphasis on Compute Subsystems (CSS) as a primary, high-margin growth engine with quantifiable long-term impact on the royalty mix.

Method	Implied Value	Weight	Weighted Value
DCF	$42.76	35%	$14.97
Comps	$55.38	60%	$33.23
Price Targets	$170.00	5%	$8.50
Total Weighted			$56.69

ARM

Company Overview

Price History